RxDoctor Payments Data

Gail Kwarciany

Oncology · Dallas, TXNPI 1649414731

Payments from drug & device makers

$3,698in general payments, 2019–2025

Across 41 payments — averaging $90.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$655
  • E.r. Squibb & Sons, L.L.C.$569
  • Merck$347
  • Gilead$263
  • Puma Biotechnology, Inc.$226
  • Regeneron Healthcare Solutions, Inc.$199
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,53296%
  • Education$1664%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few oncology providers in Texasto place this figure against a meaningful peer group, so we don't.

Other oncology in Dallas

Where these figures come from

Is this you, or does something look wrong? →